Laura Espinosa
Optometrist · Coral Gables, FLNPI 1942654116
Payments from drug & device makers
Across 131 payments — averaging $77.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$5K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$928
- Johnson & Johnson Vision Care, Inc.$725
- AbbVie$579
- Coopervision Inc.$506
- Aerie Pharmaceuticals, Inc.$469
- plus $2K from 17 others
What the payments were for
- Speaking & faculty fees$1,80018%
- Travel & lodging$7177%
- Food & beverage$7,47374%
- Education$180%
- Gifts$170%
- Entertainment$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 38 | $4,612 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $928 |
| Johnson & Johnson Vision Care, Inc. | 19 | $725 |
| AbbVie(2 entities) | 14 | $579 |
| Coopervision Inc. | 8 | $506 |
| Aerie Pharmaceuticals, Inc. | 8 | $469 |
| Tarsus Pharmaceuticals, Inc. | 8 | $325 |
| Alcon | 6 | $279 |
| Ivantis, Inc | 2 | $262 |
| Sight Sciences, Inc. | 3 | $219 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $136 |
| Sun Pharmaceutical Industries Inc. | 1 | $125 |
| Kala Pharmaceuticals, Inc. | 1 | $125 |
| Sanofi | 1 | $122 |
| Dompe US, Inc. | 2 | $119 |
| Biotissue Holdings Inc. | 1 | $107 |
| Visionix USA, Inc | 1 | $100 |
| Novartis | 5 | $88 |
| LKC Technologies, Inc. | 1 | $86 |
| Optovue, Inc. | 1 | $80 |
| Optos, Inc. | 1 | $62 |
| Carl Zeiss Meditec, Inc. | 1 | $17 |
| Oyster Point Pharma, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$3,602
- Boston 7$1,500
- BIOTRUE$1,500
- ULTRA$550
- Rhopressa$360
- Rocklatan$360
- Acuvue$240
- Hydrus$137
- LIPIFLOW SYSTEM ACTIVATOR (DISPOSABLE)$136
- ULTRA MULTIFOCAL TORIC$125
- CEQUA$125
- EYSUVIS$125
- Hydrus Microstent$125
- LUMIGAN$124
- CEREZYME$122
- LUMIZYME$122
- ALDURAZYME$122
- FABRAZYME$122
- CERDELGA$122
- XDEMVY$122
How this compares
$10,087 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 21 | $212 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Coral Gables
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$781K
- Jerry RobbenSt Augustine$663K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.